• Something wrong with this record ?

The receptor-type protein tyrosine phosphatase CD45 promotes onset and severity of IL-1β-mediated autoinflammatory osteomyelitis

J. Kralova, N. Pavliuchenko, M. Fabisik, K. Ilievova, F. Spoutil, J. Prochazka, J. Pokorna, R. Sedlacek, T. Brdicka

. 2021 ; 297 (4) : 101131. [pub] 20210827

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22003597

A number of human autoinflammatory diseases manifest with severe inflammatory bone destruction. Mouse models of these diseases represent valuable tools that help us to understand molecular mechanisms triggering this bone autoinflammation. The Pstpip2cmo mouse strain is among the best characterized of these; it harbors a mutation resulting in the loss of adaptor protein PSTPIP2 and development of autoinflammatory osteomyelitis. In Pstpip2cmo mice, overproduction of interleukin-1β (IL-1β) and reactive oxygen species by neutrophil granulocytes leads to spontaneous inflammation of the bones and surrounding soft tissues. However, the upstream signaling events leading to this overproduction are poorly characterized. Here, we show that Pstpip2cmo mice deficient in major regulator of Src-family kinases (SFKs) receptor-type protein tyrosine phosphatase CD45 display delayed onset and lower severity of the disease, while the development of autoinflammation is not affected by deficiencies in Toll-like receptor signaling. Our data also show deregulation of pro-IL-1β production by Pstpip2cmo neutrophils that are attenuated by CD45 deficiency. These data suggest a role for SFKs in autoinflammation. Together with previously published work on the involvement of protein tyrosine kinase spleen tyrosine kinase, they point to the role of receptors containing immunoreceptor tyrosine-based activation motifs, which after phosphorylation by SFKs recruit spleen tyrosine kinase for further signal propagation. We propose that this class of receptors triggers the events resulting in increased pro-IL-1β synthesis and disease initiation and/or progression.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003597
003      
CZ-PrNML
005      
20220127150055.0
007      
ta
008      
220113s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jbc.2021.101131 $2 doi
035    __
$a (PubMed)34461100
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kralova, Jarmila $u Laboratory of Leukocyte Signaling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
245    14
$a The receptor-type protein tyrosine phosphatase CD45 promotes onset and severity of IL-1β-mediated autoinflammatory osteomyelitis / $c J. Kralova, N. Pavliuchenko, M. Fabisik, K. Ilievova, F. Spoutil, J. Prochazka, J. Pokorna, R. Sedlacek, T. Brdicka
520    9_
$a A number of human autoinflammatory diseases manifest with severe inflammatory bone destruction. Mouse models of these diseases represent valuable tools that help us to understand molecular mechanisms triggering this bone autoinflammation. The Pstpip2cmo mouse strain is among the best characterized of these; it harbors a mutation resulting in the loss of adaptor protein PSTPIP2 and development of autoinflammatory osteomyelitis. In Pstpip2cmo mice, overproduction of interleukin-1β (IL-1β) and reactive oxygen species by neutrophil granulocytes leads to spontaneous inflammation of the bones and surrounding soft tissues. However, the upstream signaling events leading to this overproduction are poorly characterized. Here, we show that Pstpip2cmo mice deficient in major regulator of Src-family kinases (SFKs) receptor-type protein tyrosine phosphatase CD45 display delayed onset and lower severity of the disease, while the development of autoinflammation is not affected by deficiencies in Toll-like receptor signaling. Our data also show deregulation of pro-IL-1β production by Pstpip2cmo neutrophils that are attenuated by CD45 deficiency. These data suggest a role for SFKs in autoinflammation. Together with previously published work on the involvement of protein tyrosine kinase spleen tyrosine kinase, they point to the role of receptors containing immunoreceptor tyrosine-based activation motifs, which after phosphorylation by SFKs recruit spleen tyrosine kinase for further signal propagation. We propose that this class of receptors triggers the events resulting in increased pro-IL-1β synthesis and disease initiation and/or progression.
650    _2
$a adaptorové proteiny signální transdukční $x genetika $x imunologie $7 D048868
650    _2
$a zvířata $7 D000818
650    _2
$a cytoskeletální proteiny $x genetika $x imunologie $7 D003598
650    _2
$a diabetes mellitus 1. typu $x genetika $x imunologie $x patologie $7 D003922
650    _2
$a interleukin-1beta $x genetika $x imunologie $7 D053583
650    _2
$a antigeny CD45 $x genetika $x imunologie $7 D017493
650    _2
$a myši $7 D051379
650    _2
$a myši knockoutované $7 D018345
650    _2
$a neutrofily $x imunologie $x patologie $7 D009504
650    _2
$a osteomyelitida $x genetika $x imunologie $x patologie $7 D010019
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a signální transdukce $x genetika $x imunologie $7 D015398
650    _2
$a toll-like receptory $x genetika $x imunologie $7 D051193
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pavliuchenko, Nataliia $u Laboratory of Leukocyte Signaling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic; Charles University, Faculty of Science, Prague, Czech Republic
700    1_
$a Fabisik, Matej $u Laboratory of Leukocyte Signaling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic; Charles University, Faculty of Science, Prague, Czech Republic
700    1_
$a Ilievova, Kristyna $u Laboratory of Leukocyte Signaling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Spoutil, Frantisek $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic
700    1_
$a Prochazka, Jan $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic; Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic
700    1_
$a Pokorna, Jana $u Laboratory of Leukocyte Signaling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Sedlacek, Radislav $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic; Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic
700    1_
$a Brdicka, Tomas $u Laboratory of Leukocyte Signaling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic. Electronic address: tomas.brdicka@img.cas.cz
773    0_
$w MED00002546 $t The Journal of biological chemistry $x 1083-351X $g Roč. 297, č. 4 (2021), s. 101131
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34461100 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127150051 $b ABA008
999    __
$a ok $b bmc $g 1751151 $s 1154746
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 297 $c 4 $d 101131 $e 20210827 $i 1083-351X $m The Journal of biological chemistry $n J Biol Chem $x MED00002546
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Archiving options